Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design

Annals of the Rheumatic Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles